Cell Reports Medicine
Издатель: Elsevier · ISSN 2666-3791 · 68 статей
- A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance
- EZH2-dependent phenotypic plasticity reveals TTP-associated and mTORC1 therapeutic vulnerabilities in lethal prostate cancer
- A stem-like chromatin program in small-cell lung cancer is associated with poor outcomes after chemoimmunotherapy
- Inhibition of NLRP3 maintains microglial architecture and enhances neurological recovery after traumatic brain injury
- Spatial transcriptomics uncovers pharmacokinetic and tumor-intrinsic determinants of resistance to trastuzumab deruxtecan in breast cancer
- Toward agentic AI co-practitioners in dermatology
- Oncology LLM evaluation: From benchmark performance to clinical readiness
- Extended reality in clinical neurology: From interdisciplinary innovations to clinical practice
- Leave No Data Behind: Exploring a new paradigm in oncology with foundation models and large language models
- Therapeutic targeting of circ-ZNF609 attenuates cardiac remodeling by modulating the expression of ZEB1
- Transforming large language models into medical specialists via knowledge injection
- Retrieval-augmented generation in medicine: A scoping review of technical implementations, clinical applications, and ethical considerations
- From pelvis to brain: Clinical implications emerging from shared biology in endometriosis and migraine
- CNS targeted AAV gene therapies: Recent advances and clinical insights
- Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial
- Gut-derived glucagon-like peptides attenuate T cell-induced intestinal injury
- Isobavachalcone targets deubiquitinase OTUB1 to induce PD-L1 degradation and enhances antitumor immunity
- Lipid-engineered antibody-based therapeutics target inflamed joints and lymph nodes to enhance rheumatoid arthritis treatment
- Prognostic value of cfDNA methylation in locally advanced esophageal squamous cell cancer treated with neoadjuvant immunochemoradiotherapy
- Orally delivered metabolically reprogrammed probiotics for cascade-activated antitumor immunity in colorectal cancer
- Prediction of immunotherapy response using live tumor fragments from routine clinical biopsies
- Cell-free RNA signatures derived from the tumor microenvironment predict outcomes of CAR T therapy in large B cell lymphoma
- BT-115386, a MAT2A inhibitor, targets MTAP-deficient nasopharyngeal carcinoma via c-Myc and p53 modulation
- Reappraising muscarinic acetylcholine receptors as targets in substance use disorders
- Time-restricted feeding prevents acute liver injury by suppressing microbial anabolism of uric acid
- NKG2D overexpression potentiates CAR-T cells through costimulation by tumor NKG2D ligands
- Targeting oncogenic SOX2 condensates suppresses squamous cell carcinoma progression
- Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer
- Inhibition of the CTP synthase 1 prevents GVHD and delays skin graft rejection revealing distinct alloreactive T cell responses
- A phase 2, open-label, single-arm clinical trial of the safety and efficacy of the JAK1/3 inhibitor tofacitinib in Down syndrome